NCT00986401View on ClinicalTrials.gov

Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy
Interventions
DRUG

Trospium Chloride (Sanctura XR®)

extended release, 60 mg, oral daily

DRUG

Metformin hydrochloride (Glucophage®)

immediate release, 500mg

Trial Locations (1)

Unknown

Tempe

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00986401 - Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects | Biotech Hunter | Biotech Hunter